For example, Surrey et al. [9] analyzed the effect of a nonpeptide gonadotropin-releasing hormone (GnRH) antagonist on the reduction of fatigue in a double-blind, multicenter, randomized controlled trial (RCT) that enrolled 860 women with moderate or severe endometriosis-related pain. The gene discussed is GNRH1; the disease is endometriosis.